Get the Stockscreener App
4.15
0.48%
0.02
After Hours:
4.10
-0.05
-1.20%
Imunon Inc stock is traded at $4.15, with a volume of 24,497.
It is up +0.48% in the last 24 hours and up +5.06% over the past month.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
See More
Previous Close:
$4.13
Open:
$4.13
24h Volume:
24,497
Relative Volume:
0.28
Market Cap:
$12.74M
Revenue:
$125.00K
Net Income/Loss:
$-15.75M
P/E Ratio:
-0.6767
EPS:
-6.1327
Net Cash Flow:
$-14.57M
1W Performance:
+6.41%
1M Performance:
+5.06%
6M Performance:
-80.36%
1Y Performance:
-62.56%
1-Day Range:
$4.12
$4.25
1-Week Range:
$3.83
$4.35
52-Week Range:
$3.56
$41.22
Imunon Inc Stock (IMNN) Company Profile
Name
Imunon Inc
Sector
Industry
Phone
(609) 896-9100
Address
997 LENOX DRIVE, LAWRENCEVILLE
Compare IMNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMNN
Imunon Inc
|
4.15 | 12.68M | 125.00K | -15.75M | -14.57M | -6.1327 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Imunon Inc Stock (IMNN) Latest News
Imunon (NASDAQ:IMNN) Stock Price Up 5.3% – Should You Buy? - Defense World
Is Imunon Inc. (CBO) stock a top hedge fund pickJuly 2025 Drop Watch & Growth Focused Stock Reports - Newser
Can Imunon Inc. (CBO) stock sustain revenue momentumWeekly Risk Summary & High Accuracy Buy Signal Tips - Newser
What hedge fund moves indicate for Imunon Inc. (CBO) stockRate Hike & Safe Capital Growth Trade Ideas - Newser
How Imunon Inc. (CBO) stock reacts to monetary easingJuly 2025 Sector Moves & Consistent Profit Trade Alerts - Newser
How Imunon Inc. (CBO) stock trades pre earnings2025 Market Overview & Safe Entry Point Identification - Newser
How strong is Imunon Inc. stock revenue growthWeekly Trade Review & AI Enhanced Market Trend Forecasts - Newser
Imunon reports Q3 EPS ($1.16) vs ($3.76) last year - MSN
What analysts say about Imunon Inc stockHead and Shoulders Patterns & Affordable Market Growth - earlytimes.in
Can Imunon Inc. stock sustain institutional interestQuarterly Growth Report & Accurate Trade Setup Notifications - newser.com
Is Imunon Inc. stock trading at a premium valuationQuarterly Trade Report & Verified Momentum Stock Alerts - newser.com
Forecasting Imunon Inc. price range with options dataQuarterly Investment Review & Reliable Volume Spike Alerts - newser.com
What consensus target says about Imunon Inc. (CBO) stockMarket Activity Summary & Daily Profit Maximizing Trade Tips - newser.com
Can Imunon Inc. (CBO) stock expand revenue streamsDividend Hike & AI Optimized Trading Strategy Guides - newser.com
Is Imunon Inc. stock attractive for passive investorsWeekly Profit Analysis & Weekly Market Pulse Alerts - newser.com
Imunon, Inc. Faces Market Volatility: The Impact of Short Selling on Stock Prices - MSN
Reversal indicators forming on Imunon Inc. stock2025 Earnings Surprises & Verified Entry Point Signals - newser.com
Can Imunon Inc. stock outperform in 2025 bull marketJuly 2025 Outlook & Short-Term Trading Alerts - newser.com
What makes Imunon Inc. stock attractive to growth fundsJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - newser.com
Is Imunon Inc. stock a buy in volatile marketsJuly 2025 Momentum & Low Drawdown Momentum Trade Ideas - newser.com
What machine learning models say about Imunon Inc.Quarterly Trade Summary & Verified Momentum Stock Ideas - newser.com
Will Imunon Inc. (CBO) stock sustain bullish trend into 20252025 Analyst Calls & Real-Time Chart Breakout Alerts - newser.com
Will Imunon Inc. (CBO) stock attract long term capital inflowsQuarterly Risk Review & Free Real-Time Market Sentiment Alerts - newser.com
Is Imunon Inc. stock cheap at current valuationWeekly Profit Report & Fast Gain Stock Tips - newser.com
Signal strength of Imunon Inc. stock in tech scannersMarket Trend Summary & High Accuracy Investment Signals - newser.com
Imunon Inc Stock (IMNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):